The global cerebrospinal fluid drainage catheter market size is expected to reach USD 361.75 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028. Increasing incidences of neurological disorders, coupled with a subsequent rise in the number of surgical procedures to treat associated conditions, are expected to drive the market.
Increasing incidence of cranial and spinal injuries, trauma, and other inflammatory diseases of the cerebrospinal space is expected to promote market growth over the forecast period. For instance, as per the National Spinal Cord Injury Statistical Center estimates in 2020, approximately 294,000 Americans are currently living with SCI and 17,810 new cases of SCI are reported each year.
However, the COVID-19 emergency has negatively impacted the current market for Cerebrospinal Fluid (CSF) drainage catheters in various conducts, such as shortage of healthcare professionals and treatments for individuals suffering from neurological disorders or other medical illness during the COVID-19 pandemic. In addition, the supply chain, manufacturing activities, delivery schedules, and sales of neurological products have been disrupted owing to the restrictions at international borders, thereby affecting the market growth for the short term.
Moreover, the integration of modern technologies and the launch of innovative products by market players are likely to augment the market growth over the forecast period. For instance, in September 2017, Arkis BioSciences (Integra LifeSciences) secured FDA clearance for its new EVD catheter CerebroFlo, which is used for insertion into the ventricular cavity for CSF drainage. This catheter is currently available in the U.S. and indicated for temporary use in patients with intraventricular hemorrhage or raised intracranial pressure.
Request a free sample copy or view report summary: Cerebrospinal Fluid Drainage Catheter Market Report
Based on type, the ventricular drainage catheter segment dominated the market with a share of more than 70.0% in 2020 owing to the escalating cases of neurological disorders such as hemorrhagic and ischemic strokes, intracranial tumors, brain infection, and aneurysm
On the basis of application, the traumatic brain injury (TBI) segment dominated the market with a share of over 40.0% in 2020 owing to the high prevalence of TBIs globally, which leads to the leakage of CSF in the brain
North America dominated the market with a revenue share of over 35.0% in 2020 owing to the high prevalence rate of cerebrovascular disorders and TBIs. As per the CDC, each year, an estimated 1.5 million Americans sustain TBIs
Grand View Research has segmented the global cerebrospinal fluid drainage catheter market on the basis of type, application, and region:
CSF Drainage Catheter Type Outlook (Revenue, USD Million, 2016 - 2028)
Lumbar Drainage Catheter
Ventricular Drainage Catheter
CSF Drainage Catheter Application Outlook (Revenue, USD Million, 2016 - 2028)
Traumatic Brain Injury
Traumatic Spinal Injury
CSF Drainage Catheter Regional Outlook (Revenue, USD Million, 2016 - 2028)
Middle East and Africa (MEA)
List of Key Players of Cerebrospinal Fluid (CSF) Drainage Catheter Market
Natus Medical, Inc.
Spiegelberg GmbH & Co. KG
Integra LifeSciences Corporation
Moller Medical GmbH
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."